TABLE 1.
Study name/NCT | Author [ref.] | Population | Drug | Results | Sponsor |
Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis | Lambert [114] | In vitro: HBE, smoke exposed cells | Roflumilast and Ivacaftor | Roflumilast restores CFTR activity, ASL recovery and height post smoke exposure in vitro. Effect was additive with ivacaftor. | |
Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure | Tyrrell [116] | In vitro: HBE, smoke exposed cells | Roflumilast | Roflumilast improved cellular cAMP and ASL height recovery post smoke exposure. | |
A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. | Sloane [31] | In vitro: HBE In vivo: Smokers with and without COPD | Ivacaftor | Ivacaftor activated CFTR transport, reduced smoked induced impairment in vitro. | |
The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke. | Raju [65] | In vitro: smoke exposed cells | Ivacaftor | Ivacaftor partially restores ASL and CBF induced by cigarette smoke exposure. | |
Pilot evaluation of ivacaftor for chronic bronchitis | Solomon [120] | Chronic bronchitis: pilot study | Ivacaftor | Trend towards improved symptoms and sweat chloride. | |
Topic Trial NCT02135432 | Rowe [121] | COPD | Ivacaftor | Results pending | |
A randomized, placebo controlled 4-week study in COPD of QBW251, a potentiator of the CFTR protein | Rowe [56] | COPD | QWB251 | No improvement in lung clearance index. Improved sweat chloride, spirometry, inflammation, and sputum colonisation (figure 1). | Novartis |
Clearing Lungs with ENaC Inhibition in PCD NCT02343445 | In progress | PCD | Ivacaftor±ENaC inhibitor (VX-371) | In progress | Vertex |
HBE: human bronchial epithelium; ASL: airway surface liquid interface; CBF: ciliary beat frequency; ENaC: epithelial sodium channel; PCD: primary ciliary dyskinesia.